XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2
STATEMENTS OF CONSOLIDATED LOSS (UNAUDITED) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Net sales $ 954.2 $ 741.0 $ 1,903.0 $ 1,065.0
Costs and expenses:        
Cost of products sold, excluding depreciation and amortization and other items 898.4 673.3 1,764.3 935.8
Depreciation and amortization 27.1 25.8 54.6 39.3
Selling, general, administrative, research and development 27.5 30.9 57.7 62.7
Restructuring costs (benefit)   (0.1)   (0.8)
Other operating charges, net 3.2   3.2  
Total costs and expenses 956.2 729.9 1,879.8 1,037.0
Operating (loss) income (2.0) 11.1 23.2 28.0
Other expense:        
Interest expense (12.2) (12.4) (24.4) (24.7)
Other expense, net – Note 8 (3.7) (36.6) (5.3) (37.0)
Loss before income taxes (17.9) (37.9) (6.5) (33.7)
Income tax benefit 4.1 15.5 0.8 15.8
Net loss $ (13.8) $ (22.4) $ (5.7) $ (17.9)
Net loss per common share:        
Basic $ (0.87) $ (1.42) $ (0.36) $ (1.13)
Diluted $ (0.87) $ (1.42) $ (0.36) $ (1.13)
Weighted-average number of common shares outstanding (in thousands):        
Basic 15,899 15,835 15,883 15,820
Diluted 15,899 15,835 15,883 15,820